Scientific studies show that excess arachidonic acid increases levels of the 5-lipoxygenase (5-LOX) enzyme, which can induce undesirable effects in cells. This culminates in the excess accumulation of leukotriene B4, a pro-inflammatory compound that attacks the joints, the arterial wall, and other tissues.

In India, extracts from the Boswellia plant have been used for centuries as fluid-balancing agents. Recent human studies have confirmed that a specific Boswellia extract known as AKBA (3-O-acetyl-11-keto-ß-boswellic acid) selectively inhibits 5-LOX. Unlike other boswellic acids that only partially inhibit 5-LOX, AKBA binds directly to 5-LOX, effectively suppressing its pro-inflammatory activity. A recent study indicated that 5-LOXIN may exert its beneficial effects by controlling inflammatory responses through reducing pro-inflammatory modulators, and it may improve joint health by reducing the enzymatic degradation of cartilage. A 90-day, double-blind, randomized, placebo-controlled study demonstrated 5-LOXIN reduces joint discomfort and improves physical functioning significantly in human subjects.

Suggested Use: Take one capsule daily with or without food, or as recommended by a healthcare practitioner.